Publication Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad Antillon M, Huang C, Sutherland SA, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2023; 17 (7) : 1-29. Download PDF
Publication Estimated need for anthelminthic medicines to control soil-transmitted helminthiases in school-aged children, 2020-2030. Marocco C, Tediosi F, Bangert M, et al. Infectious diseases of poverty. 2020; 9 (1) : 48. Download PDF
Publication SCORE Operational Research on Moving toward Interruption of Schistosomiasis Transmission. Campbell C, Binder S, King C, et al. The American journal of tropical medicine and hygiene. 2020; Download PDF
Publication The challenge of ensuring equity in mass deworming programmes. Jourdan PM, Tediosi F. The Lancet. Global health. 2019; Download PDF
Publication Is the elimination of ‘sleeping sickness’ affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis in sub-Saharan Africa Sutherland S, Tediosi F. BMJ. BMJ Global Health. 2019; Download PDF
Publication Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease. Lenk E, Redekop WK, Luyendijk M, et al. PLoS neglected tropical diseases. 2018; 12 (3) : e0006250. Download PDF
Publication Global health policy and neglected tropical diseases: Then, now, and in the years to come. Fürst T, Salari P, Llamas LM, et al. PLoS neglected tropical diseases. 2017; 11 (9) : e0005759. Download PDF
Publication The socioeconomic benefit to individuals of achieving the 2020 targets for five preventive chemotherapy neglected tropical diseases. Redekop WK, Lenk E, Luyendijk M, et al. PLoS neglected tropical diseases. 2017; 11 (1) : e0005289. Download PDF
Publication Modelling the health and economic impacts of the elimination of river blindness (onchocerciasis) in Africa. Kim YE, Stolk W, Tanner M, et al. BMJ Specialist Journals. BMJ global health. 2017; Download PDF
Publication Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature. Aerts C, Sunyoto T, Tediosi F, et al. Health policy. 2017;
Publication Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage. Stone C, Kastner R, Steinmann P, et al. BMJ Specialist Journals. BMJ global health. 2016; Download PDF
Publication Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013 : Quantifying the epidemiological transition. GBD 2013 DALYs and HALE Collaborators , Murray C, Barber RM, et al. Lancet (London, England). 2015; 386 (10009 (28 November 2015)) : 2145 – 2191.
Publication Financial and economic costs of the elimination and eradication of onchocerciasis (river blindness) in Africa. Kim YE, Sicuri E, Tediosi F. PLoS neglected tropical diseases. 2015; 9 (9) : e0004056. Download PDF
Publication What is needed to eradicate lymphatic filariasis?: A model-based assessment on the impact of scaling up mass drug administration programs. Kastner R, Stone C, Steinmann P, et al. PLoS neglected tropical diseases. 2015; 9 (10) : e0004147. Download PDF
Publication Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: A systematic review. Keating J, Yukich J, Mollenkopf S, et al. Acta tropica. 2014;
Publication Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges. Tediosi F, Steinmann P, Savigny D, et al. PLoS neglected tropical diseases. 2013; 7 (11) : e2446. Download PDF